These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8995014

  • 21. The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone.
    Garnero P, Christgau S, Delmas PD.
    Bone; 2001 May; 28(5):461-4. PubMed ID: 11344044
    [Abstract] [Full Text] [Related]

  • 22. Paget's disease of bone.
    Smith R.
    J Bone Joint Surg Br; 1995 Sep; 77(5):673-4. PubMed ID: 7559686
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA.
    Henry Ford Hosp Med J; 1983 Sep; 31(4):244-8. PubMed ID: 6425243
    [No Abstract] [Full Text] [Related]

  • 24. Ibandronate treatment in Paget's disease of bone.
    Grauer A, Heichel S, Knaus J, Dosch E, Ziegler R.
    Bone; 1999 May; 24(5 Suppl):87S-89S. PubMed ID: 10321936
    [No Abstract] [Full Text] [Related]

  • 25. Paget's disease and bisphosphonates.
    Rendina D, De Filippo G, Mossetti G.
    N Engl J Med; 2005 Dec 15; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
    [No Abstract] [Full Text] [Related]

  • 26. Unusual presentation of Paget's disease of bone.
    Sathyakumar S, Kapoor N, Hephzibah J, Paul TV.
    BMJ Case Rep; 2016 Mar 04; 2016():. PubMed ID: 26944376
    [No Abstract] [Full Text] [Related]

  • 27. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE, Frölich M.
    J Clin Endocrinol Metab; 1996 Nov 04; 81(11):3993-7. PubMed ID: 8923849
    [Abstract] [Full Text] [Related]

  • 28. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD, Johnston CC, Khairi MR, Wellman H, Serafini AN, Sankey RR.
    N Engl J Med; 1973 Dec 27; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of Paget's disease of bone with porcine calcitonin.
    Eisman JA, Xipell JM, Sloman JG, Jerums G, Martin TJ.
    Med J Aust; 1974 Apr 13; 1(15):564-8. PubMed ID: 4858264
    [No Abstract] [Full Text] [Related]

  • 30. Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone.
    Reid IR, Maslowski K.
    Calcif Tissue Int; 2017 Jul 13; 101(1):43-49. PubMed ID: 28324123
    [Abstract] [Full Text] [Related]

  • 31. Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.
    Polyzos SA.
    Clin Rheumatol; 2011 Jan 13; 30(1):149-50. PubMed ID: 21053036
    [No Abstract] [Full Text] [Related]

  • 32. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
    Meunier PJ, Chapuy MC, Alexandre C, Bressot C, Edouard C, Vignon C, Mathieu L, Trechsel U.
    Lancet; 1979 Sep 08; 2(8141):489-92. PubMed ID: 90215
    [Abstract] [Full Text] [Related]

  • 33. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
    Muschitz C, Feichtinger X, Haschka J, Kocijan R.
    Wien Med Wochenschr; 2017 Feb 08; 167(1-2):18-24. PubMed ID: 27600563
    [Abstract] [Full Text] [Related]

  • 34. Effects of disodium dichloromethylene diphosphonate (CL2MDP) on Paget's disease of bone.
    Meunier PJ, Chapuy MC, Alexandre C, Bressot C, Vignon E, Trechsel U, Mathieu L, Edouard C.
    Adv Exp Med Biol; 1980 Feb 08; 128():299-309. PubMed ID: 6448538
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of Paget's disease with fluoride.
    Riggs BL, Jowsey J.
    Semin Drug Treat; 1972 Feb 08; 2(1):65-8. PubMed ID: 4558758
    [No Abstract] [Full Text] [Related]

  • 36. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
    Fritz P, Lioté F, Kuntz D.
    Semin Arthritis Rheum; 1994 Feb 08; 23(4):282. PubMed ID: 8009260
    [No Abstract] [Full Text] [Related]

  • 37. Determinants of remission of Paget's disease of bone.
    Patel S, Stone MD, Coupland C, Hosking DJ.
    J Bone Miner Res; 1993 Dec 08; 8(12):1467-73. PubMed ID: 8304048
    [Abstract] [Full Text] [Related]

  • 38. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
    Yates AJ, Percival RC, Gray RE, Atkins RM, Urwin GH, Hamdy NA, Preston CJ, Beneton MN, Russell RG, Kanis JA.
    Lancet; 1985 Jun 29; 1(8444):1474-7. PubMed ID: 2861411
    [Abstract] [Full Text] [Related]

  • 39. Mithramycin in Paget's disease.
    Epstein S.
    S Afr Med J; 1974 Jun 09; 48(31):1328-30. PubMed ID: 4276946
    [No Abstract] [Full Text] [Related]

  • 40. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
    Gennari L, Merlotti D, Mossetti G, Rendina D, De Paola V, Martini G, Nuti R.
    Mini Rev Med Chem; 2009 Aug 09; 9(9):1052-63. PubMed ID: 19689402
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.